CDKN2A and carcinoma: Among the seven genes analyzed, CDKN2A and MAGEA6 showed a progressive increase in the transcript with disease severity, whereas CTSV, FOXM1 and KRT23 gene transcript levels were higher in the carcinoma and metastatic carcinoma cell line.